EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

How do energy metabolism disorders and neuroinflammation collectively contribute to the pathogenesis of Alzheimer’s disease?

Yinuo Lei, Liyang Liu, Yi Tang

Ageing Research Reviews · 2026-10 · 121 · 103287

DOI: 10.1016/j.arr.2026.103287 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-10. Verfasst von Yinuo Lei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, National Center for Neurological…. Hauptthemen laut MEDLINE: Alzheimer Disease, Energy Metabolism, Neuroinflammatory Diseases, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 364 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Outstanding Young Talents, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD), as the leading cause of dementia, poses an increasingly severe socioeconomic burden in the context of global ageing. Traditionally defined by amyloid-β and tau pathology, it's increasingly recognized as a systems disorder in which impaired glucose metabolism, mitochondrial dysfunction, and neuroinflammation interact across neural cell types and disease stages. However, the interaction among these three mechanisms, their role in promoting the classical pathology of AD, and their verification in major neural cell types remains unclear. This review summarizes the alterations in glucose metabolism and mitochondrial metabolism in neurons, astrocytes and microglia in AD and their relationship with neuroinflammation, while also discussing some unaddressed questions, outlining therapeutic strategies, and future promising directions. Biomarkers that reflect disease stage and pathological status, multitarget therapeutic strategies, individualized precision medicine, and the integration of pharmacological with non-pharmacological interventions represent particularly promising directions for the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseEnergy MetabolismNeuroinflammatory DiseasesBrainHumansAnimalsMitochondriaMicrogliaNeuronsAstrocytesGlucose

Stichwörter der Autor:innen

Alzheimer’s diseaseGlucose metabolismMicrogliaMitochondrial metabolismNeuroinflammationType 3 diabetes mellitus

Substanzen

Glucose

Autor:innen und Institutionen

  • Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing 100053, China.
  • Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing 100053, China. Electronic address: liuliyang@xwhos…
  • Department of Neurology & Innovation Center for Neurological Disorders, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing 100053, China; Neurodegenerative Laboratory of Min…

Förderung

  • Beijing Municipal Outstanding Young Talents
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Lei, Y., Liu, L., & Tang, Y. (2026). How do energy metabolism disorders and neuroinflammation collectively contribute to the pathogenesis of Alzheimer’s disease?. Ageing Research Reviews, 121, 103287. https://doi.org/10.1016/j.arr.2026.103287

Vancouver

Lei Y, Liu L, Tang Y. How do energy metabolism disorders and neuroinflammation collectively contribute to the pathogenesis of Alzheimer’s disease?. Ageing Research Reviews. 2026;121:103287. doi:10.1016/j.arr.2026.103287

BibTeX
@article{Lei2026,
  author = {Lei, Yinuo and Liu, Liyang and Tang, Yi},
  title = {How do energy metabolism disorders and neuroinflammation collectively contribute to the pathogenesis of Alzheimer’s disease?},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {121},
  pages = {103287},
  doi = {10.1016/j.arr.2026.103287}
}
Kostenlos starten →